Evidence map›Paper›PMID 34570309›Full record

ArticleLa Radiologia medica2021

Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model.

Francesco Cellini, Rossella Di Franco, Stefania Manfrida, Valentina Borzillo, Ernesto Maranzano, Stefano Pergolizzi, Alessio Giuseppe Morganti, Vincenzo Fusco, Francesco Deodato, Mario Santarelli and 16 more

Abstract read
In one paragraph

Article in La Radiologia medica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Trial
  2. Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A COVID-era ILROG collaborative report.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Nursing Care for Metastatic Bone Cancer: Trends for the Future.International journal of environmental research and public health · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Exploring Radiologists' Burnout in the COVID-19 Era: A Narrative Review.International journal of environmental research and public health · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Radiomics in Lung Metastases: A Systematic Review.Journal of personalized medicine · 2023
    Review
  17. Immunotherapy Assessment: A New Paradigm for Radiologists.Diagnostics (Basel, Switzerland) · 2023
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Francesco CelliniDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Roma, Italia. francesco.cellini@policlinicogemelli.it.ORCID http://orcid.org/0000-0002-2145-2300
Rossella Di FrancoDepartment of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
Stefania ManfridaDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Roma, Italia.
Valentina BorzilloDepartment of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
Ernesto MaranzanoRadiotherapy Oncology Centre, Santa Maria Hospital, Terni, Italy.
Stefano PergolizziDipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università di Messina, Messina, Italy.
Alessio Giuseppe MorgantiRadiation Oncology, IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna, Italy.
Vincenzo FuscoRadiotherapy Oncology Department, IRCCS CROB, Rionero In Vulture, Italy.
Francesco DeodatoUniversità Cattolica del Sacro Cuore, Istituto di Radiologia, Roma, Italia.
Mario SantarelliRadiotherapy Unit, Ospedale San Camillo de Lellis, Rieti, Italy.
Fabio ArcidiaconoRadiation Oncology, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.
Romina RossiPalliative Care Unit IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.
Sara ReinaDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Roma, Italia.
Anna MerlottiStruttura Complessa di Radioterapia, Azienda Sanitaria Ospedaliera S. Croce e Carle, Cuneo, Italy.
Barbara Alicja Jereczek-FossaDepartment of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Angelo TozziDepartment of Radiation Oncology, ICS Maugeri SpA SB-IRCCS, Pavia, Italy.
Giambattista SiepeRadiation Oncology, IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna, Italy.
Alberto CacciolaDipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali, Università di Messina, Messina, Italy.
Elvio RussiStruttura Complessa di Radioterapia, Azienda Sanitaria Ospedaliera S. Croce e Carle, Cuneo, Italy.
Maria Antonietta GambacortaDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Roma, Italia.
Marta ScorsettiRadiotherapy and Radiosurgery dept, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.
Umberto RicardiRadiation Oncology Unit, Department of Oncology, University of Torino, Torino, Italy.
Renzo CorvòRadioterapia Oncologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Vittorio DonatoDipartimento Oncologia e Medicine Specialistiche, UOC Radioterapia, A.O. S. Camillo ‑ Forlanini, Rome, Italy.
Paolo MutoDepartment of Radiation Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.
Vincenzo ValentiniDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Roma, Italia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic has challenged healthcare systems worldwide over the last few months, and it continues to do so. Although some restrictions are being removed, it is not certain when the pandemic is going to be definitively over. Pandemics can be seen as a highly complex logistic scenario. From this perspective, some of the indications provided for palliative radiotherapy (PRT) during the COVID-19 pandemic could be maintained in the future in settings that limit the possibility of patients achieving symptom relief by radiotherapy. This paper has two aims: (1) to provide a summary of the indications for PRT during the COVID-19 pandemic; since some indications can differ slightly, and to avoid any possible contradictions, an expert panel composed of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) and the Palliative Care and Supportive Therapies Working Group (AIRO-palliative) voted by consensus on the summary; (2) to introduce a clinical care model for PRT [endorsed by AIRO and by a spontaneous Italian collaborative network for PRT named "La Rete del Sollievo" ("The Net of Relief")]. The proposed model, denoted "No cOmpRoMise on quality of life by pALliative radiotherapy" (NORMALITY), is based on an AIRO-palliative consensus-based list of clinical indications for PRT and on practical suggestions regarding the management of patients potentially suitable for PRT but dealing with highly complex logistics scenarios (similar to the ongoing logistics limits due to COVID-19). MATERIAL AND

methodsFirst, a summary of the available literature guidelines for PRT published during the COVID-19 pandemic was prepared. A systematic literature search based on the PRISMA approach was performed to retrieve the available literature reporting guideline indications fully or partially focused on PRT. Tables reporting each addressed clinical presentation and respective literature indications were prepared and distributed into two main groups: palliative emergencies and palliative non-emergencies. These summaries were voted in by consensus by selected members of the AIRO and AIRO-palliative panels. Second, based on the summary for palliative indications during the COVID-19 pandemic, a clinical care model to facilitate recruitment and delivery of PRT to patients in complex logistic scenarios was proposed. The summary tables were critically integrated and shuffled according to clinical presentations and then voted on in a second consensus round. Along with the adapted guideline indications, some methods of performing the first triage of patients and facilitating a teleconsultation preliminary to the first in-person visit were developed.

resultsAfter the revision of 161 documents, 13 papers were selected for analysis. From the papers, 19 clinical presentation items were collected; in total, 61 question items were extracted and voted on (i.e., for each presentation, more than one indication was provided from the literature). Two tables summarizing the PRT indications during the COVID-19 pandemic available from the literature (PRT COVID-19 summary tables) were developed: palliative emergencies and palliative non-emergencies. The consensus of the vote by the AIRO panel for the PRT COVID-19 summary was reached. The PRT COVID-19 summary tables for palliative emergencies and palliative non-emergencies were adapted for clinical presentations possibly associated with patients in complex clinical scenarios other than the COVID-19 pandemic. The two new indication tables (i.e., "Normality model of PRT indications") for both palliative emergencies and palliative non-emergencies were voted on in a second consensus round. The consensus rate was reached and strong. Written forms facilitating two levels of teleconsultation (triage and remote visits) were also developed, both in English and in Italian, to evaluate the patients for possible indications for PRT before scheduling clinical visits.

conclusionWe provide a comprehensive summary of the literature guideline indications for PRT during COVID-19 pandemic. We also propose a clinical care model including clinical indications and written forms facilitating two levels of teleconsultation (triage and remote visits) to evaluate the patients for indications of PRT before scheduling clinical visits. The normality model could facilitate the provision of PRT to patients in future complex logistic scenarios.

Indexed as

ConsensusCOVID-19HumansItalyNeoplasmsPalliative CarePandemicsPractice Guidelines as TopicRadiation OncologySocieties, MedicalClinical Care ModelClinical IndicationConsensusCOVID-19GuidelinesPalliationPalliative RadiotherapyQoL

Identifiers

PMID34570309
PMCPMC8475365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.